Cargando…

The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice

Atypical antipsychotic medications such as risperidone are widely prescribed for diverse psychiatric indications including schizophrenia, bipolar disorder and depression. These medications have complex pharmacology and are associated with significant endocrine and metabolic side effects. This class...

Descripción completa

Detalles Bibliográficos
Autores principales:	May, Meghan, Beauchemin, Megan, Vary, Calvin, Barlow, Deborah, Houseknecht, Karen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594635/ https://www.ncbi.nlm.nih.gov/pubmed/31242264 http://dx.doi.org/10.1371/journal.pone.0218937

Ejemplares similares

Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
por: Rostama, Bahman, et al.
Publicado: (2020)

Mechanisms Underlying Antipsychotic-Induced NAFLD and Iron Dysregulation: A Multi-Omic Approach
por: May, Meghan, et al.
Publicado: (2022)

Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk
por: May, Meghan, et al.
Publicado: (2020)

Housing Temperature Influences Atypical Antipsychotic Drug‐Induced Bone Loss in Female C57BL/6J Mice
por: Kunst, Roni F, et al.
Publicado: (2021)

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain
por: Li, Li, et al.
Publicado: (2021)

Elucidating the Mechanism(s) Underlying Antipsychotic and Antidepressant-Mediated Fractures
por: Houseknecht, Karen L., et al.
Publicado: (2017)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Liu-Seifert, Hong, et al.
Publicado: (2009)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity
por: Lugasi, L., et al.
Publicado: (2020)

Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone
por: Lugasi, Liroy, et al.
Publicado: (2020)

Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis
por: O'Sullivan, David, et al.
Publicado: (2014)

STRUCTURE OF THE D(2) DOPAMINE RECEPTOR BOUND TO THE ATYPICAL ANTIPSYCHOTIC DRUG RISPERIDONE
por: Wang, Sheng, et al.
Publicado: (2018)

Does risperidone seem safe in patients with antipsychotic-induced leukoneutropenia? Case report
por: Abid, W., et al.
Publicado: (2023)

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
por: Samalin, L, et al.
Publicado: (2010)

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole
por: Osuna-Luque, Jaime, et al.
Publicado: (2018)

Risperidone-Induced Tardive Akathisia: A Rare Antipsychotic Side Effect with Management Issues
por: Mishra, Biswa Ranjan, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
por: Gangopadhyay, Anwesha, et al.
Publicado: (2022)

CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo
por: Canfrán-Duque, Alberto, et al.
Publicado: (2021)

Histone deacetylase inhibitors mitigate antipsychotic risperidone-induced motor side effects in aged mice and in a mouse model of Alzheimer’s disease
por: Rodriguez, Guadalupe, et al.
Publicado: (2023)

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
por: Bahr, S M, et al.
Publicado: (2015)

Exposure to risperidone versus other antipsychotics and risk of osteoporosis‐related fractures: a population‐based study
por: Clapham, E., et al.
Publicado: (2019)

Involvement of the TNF-α/SATB2 axis in the induced apoptosis and inhibited autophagy of osteoblasts by the antipsychotic Risperidone
por: Zhang, Shuyao, et al.
Publicado: (2022)

A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
por: Ye, Wenyu, et al.
Publicado: (2012)

Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study
por: Vasilyeva, Irina, et al.
Publicado: (2013)

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
por: Nurmi, E L, et al.
Publicado: (2013)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

The effects of ketamine and risperidone on eye movement control in healthy volunteers
por: Schmechtig, A, et al.
Publicado: (2013)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
por: García-Cabeza, Ignacio, et al.
Publicado: (2001)

Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada
por: Lammers, Laura, et al.
Publicado: (2013)

Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia
por: Li, Zongchang, et al.
Publicado: (2015)

Polymicrobial abscess following ovariectomy in a mouse
por: Eaton, Victoria E., et al.
Publicado: (2019)

Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_31urf25cnq6manslo2mc261uef